While the minimum of 270K over may seem like a small figure when we compare it to revenue numbers of an established medtech company - this is great news. For those not in the know of how the Medtech industry operates - the first adopters will generally be these cutting edge academic hospitals, who will spread the good word / clinical data on new technology to other hospitals.
With Cleavland on board, it's only a matter of time until we get some significant traction in the rest of the market - this will be accelerated by the Phillips deal.
While the minimum of 270K over may seem like a small figure when...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $109.4M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 24.0¢ | 23.3¢ | $55.20K | 232.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 9377 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 41728 | 3 |
View Market Depth
| Last trade - 13.11pm 31/07/2025 (20 minute delay) ? |
| 4DX (ASX) Chart |